Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-180-1 | CAS number: 66170-10-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
One 28-day repeated dose toxicity study (oral administration) is available (dose levels 0, 1000, 5000, 15000 ppm). Only minor effects were seen such as increased water consumption (high dose group) and histopathological changes in the urinary bladder (high dose group, males only) and thymus (high and mid dose group, females only). The no observed adverse effect level (NOAEL) under the conditions of this study was 5,000 ppm (424.1 mg/kg body weight) in males and 1,000 ppm (90.3 mg/kg body weight) in females.
No repeated dose toxicity studies for dermal and inhalative administration are available.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 90.3 mg/kg bw/day
Additional information
28-day study (oral administration):
In a subacute toxicity study (BASF AG, 1998) Sodium ascorbyl phosphate (85.4 %) was administered to Wistar rats (5/sex/dose) in water at dose levels of 0, 1000, 5000, 15000 ppm [0, 82.8, 424.1, 1426.0 mg/kg bw/day (male); 0, 90.3, 512.0, 1661.7 mg/kg bw/day (female)]. Only minor effects were seen such as increased water consumption and histopathological changes in the urinary bladder and thymus (slight increase in starry sky cells in females). However, the toxicological relevance of these findings is regarded to be rather low as no other alteration were observed and the effects noted can be explained as:
- nonspecific inflammation (urinary bladder)
- high sodium content in test substance (water consumption).
- thymus effects only in females might also be of secondary nature (complete reversible within the 2 week-recovery period).
After a 2-week recovery period, no treatment related microscopic findings were noted, whereas the water consumption was still increased in females. There were no compound related effects in mortality, clinical signs, body weight, hematology, clinical chemistry, organ weights, or gross pathology.
Based upon the results obtained, the no observed adverse effect level (NOAEL) under the conditions of this study was 5,000 ppm (424.1 mg/kg body weight) in males and 1,000 ppm (90.3 mg/kg body weight) in females.
This subacute toxicity study in the rat is acceptable and satisfies the guideline requirement for a subchronic oral study (EU-method B.7; OECD 408) in rats.
Justification for classification or non-classification
Based on the results of the oral 28 -day repeated dose toxicity study (lowest NOAEL 90.3 mg/kg bw/day) Sodium ascorbyl phosphate is not classified according to EU Directive 67/548/EC amended and repealed by EU Regulation No.1272/2008.
Classification according to CLP/GHS:
In the 28-day repeated dose toxicity study a NOAEL of 90.3 mg/kg bw/day was reported. This NOAEL is only observed for female animals due to minor histopathological changes in the thymus (3 of 5 animals), that were completely reversible within recovery period of 14 days. The toxicological relevance of these findings is regarded to be rather low and not relevant to justify category 2 for specific target organ systemic toxicity - repeated exposure. Thus in conclusion Sodium Ascorbyl Phosphate is not classified according to CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.